fda warning letter compounded semaglutide september 2025 issued 25 letters to telehealth companies for false and misleading claims about GLP-1 products. Unlike FDA-approved drugs, these products have not been proven to be safe, effective, or of FDA Warns Telehealth Firms Over

By Route of Administration : Oral Injection The market from the oral segment is projected to gain momentum through 2032 on account of the introduction of oral formulations, which has revolutionized the market by providing a more convenient and patient-friendly option for diabetes management

There are a few tests that cover rarer STIs than Nurx, but only one also does three-site gonorrhea and chlamydia testing (myLAB Box)

No Canadian province lists Wegovy on its standard drug formulary as of 2026

[12] [22] The once-weekly administration and gradual pharmacokinetic profile may contribute to improved gastrointestinal tolerability